Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00274846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
PROCEDURE: in vitro treated peripheral blood stem cell transplantation

Sponsor

Masonic Cancer Center, University of Minnesota